Lung cancer researchers Dr Kate Sutherland and Dr Sarah Best from the Walter and Eliza Hall Institute led the research and it has been published in Nature Communications journal. They have discovered that the key to personalized or targeted therapies may be to focus on their differences. The researchers have shown that co-existing mutations can